Freeline Therapeutics Holdings
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$88,972,000 over the previous period. Total operating expenses were $95,287,000.
Profit Margin
| 2018 | 0 | -33.28M | |
|---|---|---|---|
| 2019 | 0 | -53.90M | |
| 2020 | 0 | -96.32M | |
| 2021 | 0 | -140.39M | |
| 2022 | 0 | -88.97M |
FRLN Income Statement (2018 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
Revenue | |||||
Revenue | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 1.73M | 2.38M | 1.92M | 1.54M | 0 |
Gross profit | -1.73M | -2.38M | -1.92M | -1.54M | 0 |
Operating exp. | |||||
Research and development | 66.20M | 95.43M | 76.14M | 47.04M | 34.19M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 95.28M | 137.90M | 87.18M | 53.04M | 32.71M |
Operating income | -98.44M | -142.37M | -102.44M | -63.64M | -40.98M |
Other income (expenses), net | 9.84M | 2.33M | 6.25M | 9.87M | -390K |
Income before tax | -88.60M | -140.04M | -96.19M | -53.76M | -33.25M |
Income tax expense | 368K | 342K | 129K | 141K | 27K |
Net income | -88.97M | -140.39M | -96.32M | -53.90M | -33.28M |
Earnings per share | |||||
Basic EPS | -22.52 | -58.98 | -102.09 | -127.39 | -78.65 |
Diluted EPS | -22.52 | -58.98 | -102.09 | -127.39 | -78.65 |
| Data source | Data source | Data source |